Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer-Reference-Cited by-同舟云学术

Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer

Published:2015-11-17 Issue:1 Volume:114 Page:30-36
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Loupakis Fotios,Moretto Roberto,Aprile Giuseppe,Muntoni Marta,Cremolini Chiara,Iacono Donatella,Casagrande Mariaelena,Ferrari Laura,Salvatore Lisa,Schirripa Marta,Rossini Daniele,De Maglio Giovanna,Fasola Gianpiero,Calvetti Lorenzo,Pilotto Sara,Carbognin Luisa,Fontanini Gabriella,Tortora Giampaolo,Falcone Alfredo,Sperduti Isabella,Bria Emilio

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2015399.pdf

Reference32 articles.

1. Atreya CE, Corcoran RB, Kopetz S (2015) Expanded RAS: Refining the Patient Population. J Clin Oncol 33 (7): 682–685.

2. Clancy C, Burke JP, Kalady MF, Coffey JC (2013) BRAF mutation is associated with distinct clinicopathological characteristics in colorectal cancer: a systematic review and meta-analysis. Colorectal Dis 15 (12): e711–e718.

3. Clinical Practice Guidelines in Oncology (NCCN Guidelines) (2015) Colon Cancer. Version 2. NCCN.org.

4. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA (2002) Mutations of the BRAF gene in human cancer. Nature 417 (6892): 949–954.

5. de Gramont A, Haller DG, Sargent DJ, Tabernero J, Matheson A, Schilsky RL (2010) Toward efficient trials in colorectal cancer: the ARCAD Clinical Trials Program. J Clin Oncol 28 (4): 527–530.

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and Opportunities for Precision Surgery for Colorectal Liver Metastases;Cancers;2024-06-28

2. Clinical-Molecular characteristics and Post-Translational modifications of colorectal cancer in north China: Implications for future targeted therapies;Gene;2024-03

3. Is there a prognostic difference among stage I lung adenocarcinoma patients with different BRAF‐mutation status?;Thoracic Cancer;2024-02-16

4. FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAF^V600E-Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study;Journal of Clinical Oncology;2023-09-01

5. Impact of encorafenib on survival of patients with BRAFV600E-mutant metastatic colorectal cancer in a real-world setting;Journal of Cancer Research and Clinical Oncology;2023-07-19